KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Basic) (2016 - 2026)

Quest Diagnostics' EPS (Basic) history spans 18 years, with the latest figure at $2.27 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 15.23% to $2.27 in Q1 2026 year-over-year; TTM through Mar 2026 was $9.17, a 14.48% increase, with the full-year FY2025 number at $8.87, up 14.01% from a year prior.
  • EPS (Basic) hit $2.27 in Q1 2026 for Quest Diagnostics, up from $2.21 in the prior quarter.
  • Over the last five years, EPS (Basic) for DGX hit a ceiling of $2.97 in Q1 2022 and a floor of $0.93 in Q4 2022.
  • Historically, EPS (Basic) has averaged $2.04 across 5 years, with a median of $2.01 in 2024.
  • Biggest five-year swings in EPS (Basic): tumbled 71.12% in 2022 and later surged 84.95% in 2023.
  • Tracing DGX's EPS (Basic) over 5 years: stood at $0.93 in 2022, then surged by 84.95% to $1.72 in 2023, then rose by 15.12% to $1.98 in 2024, then rose by 11.62% to $2.21 in 2025, then grew by 2.71% to $2.27 in 2026.
  • Business Quant data shows EPS (Basic) for DGX at $2.27 in Q1 2026, $2.21 in Q4 2025, and $2.18 in Q3 2025.